respiratory syncytial virus immune globulin (RSV-IGIV), an immune serum. ▪ INDICATIONS: It is used in children less than 2 years of age with bronchopulmonary dysplasia or in those born prematurely to prevent serious lower respiratory tract infection caused by respiratory syncytial virus. ▪ CONTRAINDICATIONS: Factors that prohibit its use are hypersensitivity to this drug or to other human immunoglobulin preparations and IgA deficiency. ▪ ADVERSE EFFECTS: Life-threatening effects are respiratory distress, hypoxia, anaphylaxis, and angioneurotic edema. Other adverse effects are tachypnea, rales, wheezing, fever, hypertension, tachycardia, fluid overload, diarrhea, gastroenteritis, vomiting, rash, overdose effect, and inflammation at the injection site.
